Alex Sapir, incoming Fulcrum Therapeutics CEO
May 15, 2023 11:13 AM EDTUpdated 11:24 AM
People
R&D

Still un­der clin­i­cal hold, Ful­crum locks in sea­soned com­mer­cial leader as CEO

Amber Tong

Ful­crum Ther­a­peu­tics has re­cruit­ed a new chief ex­ec­u­tive well versed in the mar­ket­ing world amid man­age­ment up­heaval, a full clin­i­cal hold for its sick­le cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Am­gen’s once-a-month obe­si­ty shot shows 20% weight loss af­ter a year

Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

A service from the Financial Times